525 related articles for article (PubMed ID: 33685103)
1. [COVID-19 vaccines increase the risk of anaphylaxis].
Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
[No Abstract] [Full Text] [Related]
2. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
3. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
[No Abstract] [Full Text] [Related]
4. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
Peter J
S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
[TBL] [Abstract][Full Text] [Related]
5. [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].
Worm M; Ring J; Klimek L; Jakob T; Lange L; Treudler R; Beyer K; Werfel T; Biedermann T; Bircher A; Fischer M; Fuchs T; Heller AR; Hoffmann F; Huttegger I; Kopp MV; Kugler C; Lommatzsch M; Pfaar O; Rietschel E; Rueff F; Schnadt S; Seifert R; Stöcker B; Vogelberg C; Sitter H; Gieler U; Brockow K
MMW Fortschr Med; 2021 Jan; 163(1):48-51. PubMed ID: 33464512
[No Abstract] [Full Text] [Related]
6. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Rama TA; Moreira A; Castells M
J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
[No Abstract] [Full Text] [Related]
7. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
8. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.
Ralph Edwards I; Lindquist M
Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947
[No Abstract] [Full Text] [Related]
9. Myocarditis Temporally Associated With COVID-19 Vaccination.
Rosner CM; Genovese L; Tehrani BN; Atkins M; Bakhshi H; Chaudhri S; Damluji AA; de Lemos JA; Desai SS; Emaminia A; Flanagan MC; Khera A; Maghsoudi A; Mekonnen G; Muthukumar A; Saeed IM; Sherwood MW; Sinha SS; O'Connor CM; deFilippi CR
Circulation; 2021 Aug; 144(6):502-505. PubMed ID: 34133885
[TBL] [Abstract][Full Text] [Related]
10. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
Book BAJ; Schmidt B; Foerster AMH
JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612
[No Abstract] [Full Text] [Related]
11. Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
Larson KF; Ammirati E; Adler ED; Cooper LT; Hong KN; Saponara G; Couri D; Cereda A; Procopio A; Cavalotti C; Oliva F; Sanna T; Ciconte VA; Onyango G; Holmes DR; Borgeson DD
Circulation; 2021 Aug; 144(6):506-508. PubMed ID: 34133884
[TBL] [Abstract][Full Text] [Related]
12. In brief: Johnson & Johnson COVID-19 vaccine suspended.
Med Lett Drugs Ther; 2021 May; 63(1623):e1. PubMed ID: 33976102
[No Abstract] [Full Text] [Related]
13. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095
[No Abstract] [Full Text] [Related]
14. Immediate reactions after mRNA SARS-CoV-2 vaccination.
Jeimy S; Wong T; Song C
CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737
[No Abstract] [Full Text] [Related]
15. Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.
Harper V; Gurugama P; Ewan P; Nasser S; Sellaturay P
Clin Exp Allergy; 2022 Mar; 52(3):465-469. PubMed ID: 34854156
[No Abstract] [Full Text] [Related]
16. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
David P; Dotan A; Mahroum N; Shoenfeld Y
Isr Med Assoc J; 2021 Jun; 23(6):378-380. PubMed ID: 34155853
[No Abstract] [Full Text] [Related]
17. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
18. [COVID-19 vaccines and cancer patients: State of the art and guidelines summary].
Kharmoum S; El M'Rabet FZ
Bull Cancer; 2021 May; 108(5):553-555. PubMed ID: 33902920
[No Abstract] [Full Text] [Related]
19. Thrombosis after covid-19 vaccination.
Hunter PR
BMJ; 2021 Apr; 373():n958. PubMed ID: 33853865
[No Abstract] [Full Text] [Related]
20. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
Bigini P; Gobbi M; Bonati M; Clavenna A; Zucchetti M; Garattini S; Pasut G
Nat Nanotechnol; 2021 Nov; 16(11):1169-1171. PubMed ID: 34732846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
